Previous investigations by Yun Ge et al. revealed that decursin inhibits tumor angiogenesis through hypoxia-inducible factor 1α (HIF-1α) ubiquitination-mediated degradation, subsequently suppressing vascular endothelial growth factor (VEGF) and carbonic anhydrase IX (CA9) expression. Here, CA9 is linked to neoplasm.